Profile data is unavailable for this security.
About the company
Supriya Lifescience Limited is an India-based manufacturer of active pharmaceutical ingredients (APIs). The Company is primarily engaged in manufacturing of bulk drugs and pharmaceutical chemicals. The Company exports its products in the antihistamine, anesthetics and anti-asthma therapy categories to approximately 86 countries. The Company's product portfolio consists of approximately 38 niche API products that address remedies in therapeutic segments, such as antihistamine, analgesic, vitamin, anesthetics and anti-asthmatics, among others. Its products include Chlorphenamine Maleate, Pheniramine Maleate, Brompheniramine Maleate, Dexchlorpheniramine Maleate, Mepyramine / Pyrilamine Maleate, Dexbrompheniramine Maleate, Cetirizine DiHCL, Diphenhydramine HCL, Bisoprolol Fumarate, Nicorandil, Mecobalamin, Hydroxocobalamin Sulphate, Hydroxocobalamin Acetate, and Hydroxocobalamin Hydrochloride, among others. The Company has manufacturing facilities located in Maharashtra.
- Revenue in INR (TTM)6.25bn
- Net income in INR1.58bn
- Incorporated2008
- Employees448.00
- LocationSupriya Lifescience LtdSonawala Road Goregoan207/208, Udyog BhavanMUMBAI 400 063IndiaIND
- Phone+91 2 240332727
- Fax+91 2 226860011
- Websitehttps://supriyalifescience.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Indoco Remedies Ltd | 17.73bn | 320.40m | 28.37bn | 5.93k | 92.29 | 2.60 | 20.82 | 1.60 | 3.34 | 3.34 | 175.26 | 118.23 | 0.8194 | 1.52 | 4.51 | 2,989,727.00 | 1.36 | 6.88 | 1.99 | 9.85 | 68.34 | 65.59 | 1.66 | 6.93 | 0.8142 | 1.71 | 0.4339 | 14.02 | 8.91 | 13.41 | -30.78 | -- | 34.54 | 37.97 |
| Dishman Carbogen Amcis Ltd | 24.16bn | -2.48bn | 29.71bn | 1.13k | -- | -- | 172.03 | 1.23 | -15.81 | -15.81 | 154.06 | -- | -- | -- | -- | 21,344,260.00 | -- | -0.3986 | -- | -0.4888 | 79.30 | 73.83 | -10.27 | -1.54 | -- | -0.7216 | -- | -- | 8.41 | 4.91 | -414.93 | -- | -0.3175 | -- |
| RPG Life Sciences Limited | 6.00bn | 923.20m | 41.14bn | 1.27k | 44.56 | -- | 37.24 | 6.86 | 55.82 | 55.82 | 362.60 | -- | -- | -- | -- | 4,721,969.00 | -- | 16.07 | -- | 21.77 | 68.42 | 62.99 | 15.39 | 11.99 | -- | 220.43 | -- | 29.27 | 13.50 | 12.01 | 29.60 | 51.98 | 28.60 | 46.14 |
| Jeena Sikho Lifecare Ltd | -100.00bn | -100.00bn | 42.42bn | 1.23k | -- | 134.16 | -- | -- | -- | -- | -- | 12.72 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.8228 | -- | 0.2681 | -- | 43.84 | -- | 77.37 | -- | -- | -- |
| Solara Active Pharma Sciences Ltd | 12.22bn | -5.36bn | 44.30bn | 2.16k | -- | 2.65 | -- | 3.63 | -137.13 | -137.13 | 320.29 | 301.63 | 0.4731 | 1.77 | 2.69 | 5,667,023.00 | -20.76 | -2.44 | -36.40 | -3.84 | 38.70 | 41.16 | -43.89 | -4.49 | 0.448 | -1.30 | 0.4355 | -- | -10.73 | -1.45 | -2,458.12 | -- | -4.81 | -- |
| Aarti Drugs Ltd | 23.80bn | 1.52bn | 44.72bn | 1.06k | 29.48 | 3.50 | 21.75 | 1.88 | 16.62 | 16.62 | 259.74 | 139.96 | 0.9954 | 3.16 | 3.43 | 22,364,630.00 | 6.37 | 9.73 | 9.62 | 15.78 | 34.60 | 22.23 | 6.40 | 8.25 | 1.01 | 6.83 | 0.3159 | -- | -6.90 | 10.13 | 3.07 | 13.82 | 24.96 | -- |
| Morepen Laboratories Ltd | 17.45bn | 1.18bn | 45.67bn | 1.62k | 36.07 | -- | 30.52 | 2.62 | 2.31 | 2.31 | 34.26 | -- | -- | -- | -- | 10,749,300.00 | -- | 7.90 | -- | 13.34 | 37.86 | 33.34 | 6.77 | 5.49 | -- | 33.34 | -- | 0.00 | 19.25 | 17.08 | 148.63 | 27.22 | 47.03 | -- |
| Hikal Ltd | 18.03bn | 677.82m | 47.71bn | 2.06k | 70.43 | -- | 25.18 | 2.65 | 5.49 | 5.49 | 145.97 | -- | -- | -- | -- | 8,749,879.00 | -- | 5.07 | -- | 7.51 | 53.06 | 46.78 | 3.76 | 5.86 | -- | 2.45 | -- | 12.19 | -11.79 | 2.34 | -11.20 | -7.55 | 9.72 | 0.00 |
| Gufic BioSciences Ltd | 8.14bn | 863.69m | 48.68bn | 1.45k | 55.81 | -- | 47.05 | 5.98 | 8.70 | 8.70 | 81.95 | -- | -- | -- | -- | 5,624,707.00 | -- | 11.46 | -- | 19.21 | 52.39 | 45.79 | 10.60 | 10.46 | -- | 8.09 | -- | 1.31 | 16.80 | 18.12 | 8.07 | 31.46 | 53.83 | 14.87 |
| Supriya Lifescience Ltd | 6.25bn | 1.58bn | 52.18bn | 448.00 | 33.18 | 5.76 | 29.85 | 8.35 | 19.54 | 19.54 | 77.55 | 112.56 | 0.6737 | 2.01 | 6.56 | 13,950,510.00 | 16.98 | 19.08 | 18.38 | 24.04 | 66.81 | 57.12 | 25.20 | 24.71 | 4.05 | 111.46 | 0.006 | 2.88 | 23.74 | 15.47 | 32.56 | 24.75 | 83.79 | -- |
| SeQuent Scientific Ltd | 14.27bn | 54.87m | 53.14bn | 1.20k | 997.47 | -- | 68.41 | 3.72 | 0.2137 | 0.2137 | 57.18 | -- | -- | -- | -- | 11,939,190.00 | -- | 1.09 | -- | 1.76 | 45.38 | 41.97 | 0.9902 | 1.18 | -- | 0.9009 | -- | 35.06 | -3.60 | 5.68 | 70.40 | -- | 6.96 | -- |
| Innova Captab Ltd | 11.42bn | 1.06bn | 54.45bn | -- | 40.16 | -- | 43.83 | 4.77 | 23.69 | 23.69 | 236.62 | -- | -- | -- | -- | -- | -- | 10.82 | -- | 18.38 | 33.38 | 25.18 | 9.30 | 8.04 | -- | 8.89 | -- | -- | 16.72 | 24.90 | 38.84 | 36.55 | 104.14 | -- |
| Aarti Pharmalabs Ltd | 19.68bn | 2.28bn | 59.70bn | 1.63k | 26.18 | 3.22 | 19.44 | 3.03 | 25.16 | 25.16 | 217.12 | 204.88 | 0.7733 | 1.62 | 4.59 | 12,095,750.00 | 8.96 | -- | 11.86 | -- | 45.56 | -- | 11.59 | -- | 0.9611 | 17.12 | 0.1723 | -- | -4.76 | -- | 12.10 | -- | -- | -- |
| Unichem Laboratories Ltd | 17.28bn | -605.50m | 63.34bn | 3.19k | -- | -- | 121.24 | 3.67 | -8.59 | -8.59 | 245.15 | -- | -- | -- | -- | 5,410,587.00 | -- | -1.67 | -- | -2.03 | 62.00 | 56.18 | -3.50 | -3.99 | -- | 0.1401 | -- | -- | 26.94 | 7.64 | 65.15 | -- | -35.00 | -- |
| Sun Pharma Advanced Research Co Ltd | 600.85m | -4.09bn | 67.32bn | 409.00 | -- | -- | -- | 112.04 | -12.60 | -12.60 | 1.85 | -2.38 | 0.1216 | -- | 2.66 | 1,469,078.00 | -82.71 | -61.70 | -164.56 | -119.31 | 51.18 | 74.49 | -680.16 | -163.40 | -- | -145.15 | 4.25 | -- | -68.36 | -16.21 | -73.96 | -- | 15.40 | -- |
Data as of Nov 08 2024. Currency figures normalised to Supriya Lifescience Ltd's reporting currency: Indian Rupee INR
3.95%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Aditya Birla Sun Life Insurance Co. Ltd.as of 30 Sep 2024 | 2.41m | 3.00% |
| ITI Asset Management Ltd. (India)as of 31 Oct 2024 | 407.97k | 0.51% |
| Dimensional Fund Advisors LPas of 03 Oct 2024 | 99.01k | 0.12% |
| Motilal Oswal Asset Management Co. Ltd.as of 31 Oct 2024 | 58.51k | 0.07% |
| WhiteOak Capital Asset Management Ltd.as of 30 Sep 2024 | 51.81k | 0.06% |
| Acadian Asset Management LLCas of 30 Sep 2024 | 42.15k | 0.05% |
| Quantum Asset Management Co. Pvt Ltd.as of 31 Oct 2024 | 41.78k | 0.05% |
| Dimensional Fund Advisors Ltd.as of 31 Aug 2024 | 26.10k | 0.03% |
| SSgA Funds Management, Inc.as of 03 Oct 2024 | 25.78k | 0.03% |
| Aditya Birla Sun Life Amc Ltd. (Investment Management)as of 30 Sep 2024 | 12.16k | 0.02% |
More ▼
Data from 30 Jun 2024 - 31 Oct 2024Source: FactSet Research Systems Inc.
